Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics

Pediatric Infectious Disease Journal

Volumn 17, Issue 6, 1998, Pages 463-469

  Leibovitz, Eugene ^a   Raiz, Simon ^a   Piglansky, Lolita ^a   Greenberg, David ^a   Yagupsky, Pablo ^a   Fliss, Dan M ^a   Leiberman, Alberto ^a   Dagan, Ron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute otitis media; Antibiotic resistance; Antibiotics; Haemophilus influenzae; Streptococcus pneumoniae

Indexed keywords

CEFACLOR; CEFUROXIME; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MICROBIAL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; OTITIS MEDIA WITH EFFUSION; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

EID: 0031833659     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199806000-00005     Document Type: Article

References (38)

1. Baquero F, Loza E. Antibiotic resistance of microorganisms involved in ear, nose and throat infections. Pediatr Infect Dis J 1994;13:S9-14.
2. Neu HC. Otitis media: antibiotic resistance of causative pathogens and treatment alternatives. Pediatr Infect Dis J 1995;14:S51-6.
3. Gehanno P, Lenoir G, Berche P. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother 1995;39:271-2.
4. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J 1996;15:980-5.
5. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis 1997;176:1253-9.
6. Teele DW, Pelton SI, Klein JO. Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy. J Pediatr 1981;98:537-9.
7. Harrison CJ, Marks MI, Welch DF. Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis J 1985;4:641-6.
8. Bernstein J, Stanievich J, Brodsky L, Ogra PL. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol 1992;101:87-91.
9. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J 1995;14:178-83.
10. Pichichero ME. Persistent acute otitis media: II. Antimicrobial treatment. Pediatr Infect Dis J 1995;14:183-8.
11. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility and antimicrobial management. Pediatr Infect Dis J 1995;14:751-9.
12. Leibovitz E, Abramson O, Greenberg D, et al. Correlation between MIC values and bacteriologic outcome in pneumococcal acute otitis media [Abstract LM60]. In: Program and abstracts of the 36th International Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 15 to 18, 1996. Washington, DC: American Society for Microbiology, 1996.
13. Howie VM. Eradication of bacterial pathogens from middle ear infection. Clin Infect Dis 1992:14(Suppl 2):209-10.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Sixth Informed Supplement. NCCLS Document M100-S6. vol 15, no. 14. Villanova, PA: National Committee for Clinical Laboratory Standards, 1995.
15. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992;11:S7-11.
16. Jacobs MR. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatr Infect Dis J 1996;15:940-3.
17. Appelbaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 1996;15:932-9.
18. Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J 1997;16:449-56.
19. Dagan R, Yagupsky P, Goldbart A, Wasas A, Klugman K. Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: implications for future immunization policies. Pediatr Infect Dis J 1994;13: 782-6.
20. Hoberman A, Paradise J, Block S, Burch DJ, Jacobs MR, Balanescu M. Efficacy of amoxicillin-clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. Pediatr Infect Dis J 1996;15:955-62.
21. Marchant CD, Shurin PA, Johnson CE, et al. A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. J Pediatr 1986; 109:891-6.
22. Patel JA, Reisner B, Vizirinia N, Owen M, Chonmaitree T, Howie V. Bacteriologic failure of amoxicillin/clavulanate in treatment of acute otitis media caused by nontypable Haemophilus influenzae. J Pediatr 1995;126:799-806.
23. Dagan R, Leibovitz E, Fliss DM, Yagupsky P, Leiberman A. Early eradication of pathogens from middle ear fluid during treatment of acute otitis media is associated with improved clinical outcome [Abstract K24]. In: Program and abstracts of the 36th International Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 15 to 18, 1996. Washington, DC: American Society for Microbiology, 1996.
24. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon." J Pediatr 1992; 120:72-7.
25. Gudnason TH, Sigurdardottir LY, Kristinsson KG, Kristjansson K, Laxdal TH. One dose ceftriaxone treatment of otitis media caused by multi-resistant pneumococci [Abstract LM24]. In: Program and abstracts of the 36th International Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 15 to 18, 1996. Washington, DC: American Society for Microbiology, 1996.
26. McCracken GH. Microbiologic activity of the newer macrolide antibiotics. Pediatr Infect Dis J 1997;16:432-7.
27. McCarthy J. A multicenter, open label trial of azithromycin for the treatment of children with acute otitis media. Pediatr Infect Dis J 1996;15:S10-14.
28. Aronovitz G. A multicenter, open label trial of azithromycin vs. amoxicillin/clavulanate for the management of acute otitis media in children. Pediatr Infect Dis J 1996;15:S15-9.
29. McLinn S. A multicenter, double blind comparison of azithromycin and amoxicillin/clavulanate for the treatment of acute otitis media in children. Pediatr Infect Dis J 1996;15:S20-3.
30. Dagan R, Leibovitz E, Jacobs M, Fliss DM, Leiberman A, Jagupsky P. Bacteriologic response in acute otitis media caused by Haemophilus influenzae treated with azithromycin, [Abstract K102]. In: Program and abstracts of the 37th International Conference on Antimicrobial Agents and Chemotherapy, Toronto, September 28 to October 1, 1997. Washington, DC: American Society for Microbiology, 1997.
31. Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics 1993;91:23-30.
32. Chamberlain JM, Boenning DA, Waisman Y, Ochsenschlager DW, Klein BL. Single-dose ceftriaxone versus 10 days of cefaclor for otitis media. Clin Pediatr 1994;33:642-6.
33. Barnett ED, Teele DW, Klein JO, Cabral HJ, Kharasch SJ. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Pediatrics 1997;99:23-8.
34. Leibovitz E, Piglansky L, Reis S, et al. Bacteriologic efficacy of 3-day intramuscular ceftriaxone in nonresponsive acute otitis media [Abstract K105]. In: Program and abstracts of the 37th International Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997. Washington, DC: American Society for Microbiology, 1997.
35. Howie VM, Ploussard JH. The "in vivo" sensitivity: bacteriology of middle ear exudate. Pediatrics 1969;44:940-4.
36. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 1993;12:973-5.
37. McCarthy JM. Bacterial susceptibility and tympanocentesis in acute otitis media. Pediatr Infect Dis J 1995;14:S45-50.
38. Berman S. Acute otitis media unresponsive to treatment. Clin Microbiol Infect 1997;3:S49-50.